Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 15, 2018
Pharmacy Choice - News - Front Page Healthcare News - October 15, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/8/18 - 3D Display Market Worth $193.24 Billion by 2023 - Exclusive Report by Allied Market Research
Increasing demand for 3 D visualization in show business, gaming, medical, and defense sectors and advancements in OLED and LED technologies would boost the growth of the global 3 D display market. Allied Market Research recently published a report, titled, 3 D Display Market by Type, Technology, Access Method, and Application: Global Opportunity A
10/8/18 - 6th, 14th Congressional District hopefuls weigh in on health care
Congressional candidates in Illinois' 6th and 14th Districts have been divided about matters such as how big of a role government should play in health care and whether the Affordable Care Act should be fully dismantled. Randy Hultgren, 14th Congressional District. Hultgren, R- Plano, said one of the differences between his beliefs and those of his
10/8/18 - ACACIA PHARMA PROVIDES UPDATE ON FDA REGULATORY REVIEW OF BARHEMSYS(TM)
*FDA issued a Complete Response letter to Acacia Pharma on Friday 5 October* Only issue raised relates to FDA inspection of contract manufacturer of active ingredient* No other quality or manufacturing deficiencies noted* No clinical safety or efficacy issues identified and no requirement for further clinical studies or data analyses* Conference ca
10/8/18 - Adamas Presents Final Results from the Two-Year, Phase 3 Open-Label Study of GOCOVRI? in Parkinson's Disease Patients with Dyskinesia
Adamas Pharmaceuticals, Inc., a fully integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, today announced the presentation of final results from EASE LID 2, the company s two-year Phase 3 open-label study of GOCOVRI? extended release capsules, the first and only medicine approved by the
10/8/18 - Alnylam Reports Updated Positive Results from Phase 1/2 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1
CAMBRIDGE- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today updated positive results from its Phase 1/ 2 clinical study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic targeting glycolate oxidase for the treatment of primary hyperoxaluria type 1. Results were presented at the 2018.
10/8/18 - American HealthTech Announces the Availability of Two New Products and an Improved User Experience with Their Latest EHR Release
American HealthTech, a wholly owned subsidiary of CPSI and a leading provider of electronic health records for the post-acute and senior living markets, is pleased to announce the general availability of their new user experience and two new licensable products that are designed around key clinical workflow. In commenting on the announcement, Chris
10/8/18 - Animal Antibiotics Market Forecast Based on Trends, Size, Share and Upcoming Opportunity Through 2018-2028: Animal antibiotics are used by farmers to prevent animals from suffering from infectious diseases. They are added to animal feed to improve it
Rockville, MD 10/08/2018 Animal antibiotics are used by farmers to prevent animals from suffering from infectious diseases. They are added to animal feed to improve its efficiency as well as promote the growth of animals. The addition of animal antibiotics such as tetracycline and penicillin to the chicken feed improves the egg production and
10/8/18 - Ansun Biopharma Announces Key Appointments to its Executive Management Team
Stanley Lewis, MD, MPH joins Ansun as its Chief Medical Officer, where he will oversee the clinical development of DAS181, Ansun's lead experimental product. Dr. Lewis joins Ansun from TaiMed Biologics, where as Chief Medical Officer, he spent the past ten years successfully leading the development of TROGARZO from an early stage compound to FDA
10/8/18 - Anti Epilepsy Drugs Market Outlook 2018 to 2023 Perceive Accruals USD 4.8 Billion with Worldwide Leading Players Pfizer, Johnson & Johnson, UCB Pharma and More
Anti-Epilepsy Drugs Market Report include on MarketReseacrhFuture.com with Extensive Study. The report aims to provide an Overview of Anti-Epilepsy Drugs Market Report. According to the World Health Organization in 2017, approximately 50 million people across the globe have epilepsy, making it one of the most common neurological diseases globally.
10/8/18 - Antibiotics Market Is Projected To Grow Rapidly Owing To Increasing Research & Development by Pharmaceutical Companies Till 2024 | Million Insights
According to new report available with Million Insights, global antibiotics industry report on is foretold to provide a robust support for industry players to lay a solid foundation for their business growth. It includes a comprehensive evaluation of the market's growth status and market risk. The global Antibiotics Market is likely to grow at a...
10/8/18 - Armas and Shilpa Enter into a Sales and Distribution Agreement to Bring High quality oncology products to U.S. Market
MANALAPAN, N.J. and KARNATAKA, India October 08, 2018. Armas Pharmaceuticals Inc., a NJ based pharmaceutical marketing& distribution corporation, and Shilpa Medicare Limited, an India based pharmaceutical company, have announced today, a distribution partnership agreement. "We are extremely pleased to have an opportunity to partner with Shilpa Med
10/8/18 - Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen
PASADENA- Arrowhead Pharmaceuticals Inc. today announced that it entered into a license and collaboration agreement with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson& Johnson, to develop and commercialize ARO-HBV. Separately, Johnson& Johnson Innovation- JJDC, Inc. will make a $75 million equity investment
10/8/18 - Bausch Health's BRYHALI?(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced that the U.S. Food and Drug Administration has provided tentative approval of the New Drug Application for BRYHALI? Lotion, 0.01%, for the topical treatment of plaque psoriasis in ad
10/8/18 - Biopharmaceutical CMO & CRO Global Market Analysis, Growth, Opportunities, Top Key Players and Forecast to 2025
WiseGuyRerports.com Presents " Global Biopharmaceutical CMO& CRO Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023" New Document to its Studies Database. U.S is estimated to have the largest number of biomanufacturing facilities, which in turn, has resulted in the largest share of North America region. The Asia-Pacific
10/8/18 - BioXcel Therapeutics Announces Submission of IND for Lead Immuno-oncology Candidate, BXCL701, in Treatment Emergent Neuroendocrine Prostate Cancer
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical development company utilizing novel artificial intelligence approaches to identify the next wave of medicines across neuroscience and immuno-oncology, today announced it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to evaluate its lead
10/8/18 - Blood Bank (Blood Banking) 2018: Global Trend, In-Depth Research, Therapeutics area analysis and Forecast to 2023
Wiseguyreports.Com Added New Market Research Report On- " Blood Bank Market 2018 Key Players, Applications and Future Demand Forecast to 2023". This report studies the Blood Bank market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global
10/8/18 - CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Among World's Biggest Holders of Cannabis Patents
via CannabisNewsWire CannabisNewsAudio announces the Audio Press Release titled Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector, featuring Lexaria Bioscience Corp... Outside of China, Lexaria is one of the world s biggest holders of cannabis patents with eight patents already granted. Lexaria has disclosed i
10/8/18 - Cell Therapy Market: Advancements, Key Players, Strategies to Boost Industry Growth and Revenue By 2023
Cell Therapy Market Information: By Type, Technology, Cell Source, Application, End User- Global Forecast till 2023. The global cell therapy market is due to grow at a CAGR of 10.6% during the forecast period of 2017 to 2023 according to Market Research Future's latest report on the subject. Cell therapy has emerged as a transformative field in bio
10/8/18 - Cidara Therapeutics Presents Results from Successful Phase 2 STRIVE Trial Evaluating Rezafungin at IDWeek 2018
SAN DIEGO- Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced the presentation of data from the company's Phase 2 STRIVE trial of rezafungin at IDWeek 2018, taking place in San Francisco from October 3-7. The STRIVE data will be presented by George R. Thompson, M.D., Princi
10/8/18 - City Council allows bond sale for Benedictine Health System to purchase facilities
The City Council took the first of two steps to turning the Benedictine Living Community of St. The city originally financed the construction of the skilled nursing facility, 1907 Klein St., and assisted living residence, 1906 Sunrise Drive, under a 2006 agreement. "The city was looking for a qualified nursing home operator," City Administrator To
10/8/18 - Cocrystal Pharma Announces Clinical Trial Agreement for Investigator-Initiated Phase 2a Study in Hong Kong of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus
Cocrystal Pharma, Inc.,, a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, announced today that it has signed a Clinical Trial Agreement for an investigator-initiated study with the Humanity& Health Research Centre, Hong Kong, PR China. Under the Clinical Trial Agreement, the Phase 2 a study of CC-312
10/8/18 - Cyclacel Pharmaceuticals and MD Anderson Cancer Center Announce Strategic Alliance to Study Novel Cyclacel Medicines in Hematological Malignancies
BERKELEY HEIGHTS- Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines based on cancer cell biology, and The University of Texas MD Anderson Cancer Center today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in...
10/8/18 - DaVita's Inpatient Hospital Services Program Reaccredited by The Joint Commission
DaVita Kidney Care, a division of DaVita Inc., a leading independent provider of integrated health and kidney care services in the United States, today announced DaVita Hospital Services has received its second reaccreditation for Ambulatory Health Care from The Joint Commission. The reaccreditation, effective 2018, is a symbol of quality earned
10/8/18 - Dental Panoramic Radiography Market to Register Substantial Expansion by 2024
Albany, NY 10/08/2018 Dental panoramic radiography is a technique which produces single tomographic images of facial structures, which includes both the maxillary and mandibular dental arches, and their supporting structures. It displays a two-dimensional image of the teeth, from ear-to-ear, by taking images at multiple planes to prepare a co
10/8/18 - Diagnostic Imaging Devices Market - Global Forecast to 2025: Increasing Investments By Government And Private Bodies To Modernize Diagnostic Imaging Facilities
The "Diagnostic Imaging Devices Global Market- Forecast to 2025" report has been added to ResearchAndMarkets.com' s offering.. The diagnostic imaging devices global market is expected to grow at a medium single digit CAGR to reach $46,481.7 million by 2025.. The use of diagnostic imaging devices is increasing significantly due to increased demand
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415